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Krüppel-like transcription factors (Klfs), each of which contains a CACCC-box binding domain, have been
investigated in a variety of developmental processes, such as angiogenesis, neurogenesis and somatic-
cell reprogramming. However, the function and molecular mechanism by which the Klf family acts
during developmental hematopoiesis remain elusive. Here, we report identiﬁcation of 24 Klf family genes
in zebraﬁsh using bioinformatics. Gene expression proﬁling shows that 6 of these genes are expressed in
blood and/or vascular endothelial cells during embryogenesis. Loss of function of 2 factors (klf3 or klf6a)
leads to a decreased number of mature erythrocytes. Molecular studies indicate that both Klf3 and Klf6a
are essential for erythroid cell differentiation and maturation but that these two proteins function in
distinct manners. We ﬁnd that Klf3 inhibits the expression of ferric-chelate reductase 1b (frrs1b), thereby
promoting the maturation of erythroid cells, whereas Klf6a controls the erythroid cell cycle by negatively
regulating cdkn1a expression to determine the rate of red blood cell proliferation. Taken together, our
study provides a global view of the Klf family members that contribute to hematopoiesis in zebraﬁsh and
sheds new light on the function and molecular mechanism by which Klf3 and Klf6a act during ery-
thropoiesis in vertebrates.
& 2015 Elsevier Inc. All rights reserved.Introduction
Zebraﬁsh has been recognized as an ideal genetic and devel-
opmental biology model to study vertebrate hematopoiesis owing
to its special characteristics. The physiological and molecular
mechanisms underlying hematopoiesis are well conserved from
zebraﬁsh to higher vertebrates, including mammals. There are two
distinct waves of hematopoiesis in vertebrates: primitive hema-
topoiesis and deﬁnitive hematopoiesis (Davidson and Zon, 2004).
Primitive erythropoiesis and myelopoiesis are initiated during the
primitive wave; however, hematopoietic stem cells (HSCs) are
produced only during the deﬁnitive wave. Many genes participate
in the regulation of the complex process of hematopoiesis, such as
klf genes during erythropoiesis; ets genes during hemangioblast
differentiation, angiogenesis and HSC development; and runx1 and
cmyb during HSC emergence (Dzierzak and Speck, 2008; Liu and
Patient, 2008; North et al., 2002; Oates et al., 2001; Wang et al.,
2013). However, our understanding of Klf's role during ery-
thropoiesis is still incomplete.
The Krüppel-like transcription factors (Klfs) are well-knowngroups/liufeng/PI/.master regulators that are involved in various biological processes
during embryogenesis. Members of the Klf family are character-
ized by Cys2-His2 zinc ﬁnger motifs at the C-terminus that bind to
the sequence CACCC or to GC-rich elements of DNA, whereas the
variable N-terminus is able to recruit different cofactors to func-
tion as activators or repressors, such as Klf5, Klf6, Klf7 and Klf16
(Conkright et al., 1999; Kaczynski et al., 2002; Koritschoner et al.,
1997; Matsumoto et al., 1998; Nagai et al., 2009). Such cooperation
is highly conserved in zebraﬁsh and mammals (Miller and Bieker,
1993; Shields and Yang, 1998). Additionally, other factors inﬂuence
Klf function in vivo, such as epigenetic modiﬁcation (Chen and
Bieker, 2004; Ma et al., 2013) and cellular context (Botella et al.,
2002; Eaton et al., 2008; Fischer et al., 2001; Matsumoto et al.,
2006; Porcu et al., 2011; Stadhouders et al., 2012; Xue et al., 2014).
The functions of several Klf factors during development have
been investigated. klf1, which is also known as eklf, is highly ex-
pressed in erythroid cells in both the yolk sac and the fetal liver
(Miller and Bieker, 1993). By directly binding to the promoter of
the beta-globin gene, Klf1 regulates the globin switch to guide the
differentiation of erythrocytes (Donze et al., 1995). In addition, klf4
functions as a tumor suppressor in many organs (Guan et al., 2010;
Zammarchi et al., 2011) and is now well known as one of the Ya-
manaka factors for the generation of induced pluripotent stem
cells (iPSCs) from mouse ﬁbroblasts in vitro (Takahashi and Ya-
manaka, 2006). klf2a is expressed in the heart tube and
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development (Lee et al., 2006; Vermot et al., 2009) and primitive
hematopoiesis (Alhashem et al., 2011; Basu et al., 2007; Basu et al.,
2005; Pang et al., 2012). We have previously demonstrated that
blood ﬂow-dependent klf2a expression regulates HSC develop-
ment by mediating NO signaling in zebraﬁsh embryos (Wang et al.,
2011).
Although ﬁrst identiﬁed as a weak activator (Crossley et al.,
1996), Klf3 also acts as a transcriptional repressor. By binding to
the cofactors (such as CtBP) (Crossley, 1998) that recruit other
factors (such as chromatin modifying enzyme (Shi et al., 2003)),
Klf3 represses transcription during several signiﬁcant biological
processes, including adipogenesis (Sue et al., 2008), B cell devel-
opment (Turchinovich et al., 2011), erythropoiesis (Crossley et al.,
1996), muscle cell development (Haldar et al., 2007) and cardio-
vascular development (Kelsey et al., 2013). During erythropoiesis,
the expression of klf3 is directly regulated by Klf1; Klf3 then re-
presses the expression of non-erythroid genes (Funnell et al.,
2012), which might partially contribute to erythroid progenitor
differentiation. Nevertheless, the downstream mechanism of ac-
tion of Klf3 has not yet been illustrated.
Klf6 was originally identiﬁed as a tumor suppressor that in-
hibited cancer cell proliferation in prostate cancer (Narla et al.,
2001). Mutations or alternative splicing variants of klf6 increase
the risk of cancers such as lung cancer, ovarian cancer, human
hepatocellular carcinoma and glioblastoma (DiFeo et al., 2008;
DiFeo et al., 2006; Narla et al., 2007; Tchirkov et al., 2010). How-
ever, during organogenesis, Klf6 induces cellular proliferation and
promotes the growth of internal organs. Studies have shown that
hepatocyte proliferation was decreased after klf6a (the zebraﬁsh
homolog of the mouse klf6) was knocked down in zebraﬁsh (Zhao
et al., 2010). klf6 is an important regulator of yolk sac hemato-
poiesis in mice (Matsumoto et al., 2006) and is also essential for
the processes of nerve regeneration and vascular remodeling
(Botella et al., 2002; Garrido-Martin et al., 2013; Veldman et al.,
2007). However, whether klf6 functions in primitive erythropoiesis
in other vertebrates remains unknown.
Here, we used zebraﬁsh as a model to obtain a global view of
the expression of the Klf family members, focusing on the Klf
factors involved in hematopoiesis in vivo. Our studies represent a
comprehensive analysis of the Klf family during embryogenesis in
vertebrates and provide insights into the functions and mechan-
isms of action of klf3 and klf6a in hematopoiesis. Loss of klf3, klf6a
or both led to more erythroid progenitors and fewer mature ery-
throcytes, indicating a signiﬁcant role for Klf factors during the
initial progression of erythroleukemia and/or anemia.Materials and methods
Zebraﬁsh
Zebraﬁsh embryos were maintained via the natural spawning
of adult zebraﬁsh. Zebraﬁsh embryos were raised at 28.5 °C in
system water and staged as described previously (Kimmel et al.,
1995). The ﬂk1:GFP/gata1:dsRed transgenic line (Jin et al., 2007)
and the etsrpy11 mutant (Pham et al., 2007) were kindly provided
by Stefan Schulte-Merker (Hubrecht Institute, Utrecht, The Neth-
erlands) and Brant Weinstein (NIH), respectively. The cloche mu-
tant (Stainier et al., 1995), the moonshine mutant (Ransom et al.,
2004) and the p53 mutant (Tao et al., 2013) were kindly provided
by Anming Meng (Tsinghua University, Beijing, China). This study
was approved by the Ethical Review Committee of the Institute of
Zoology, Chinese Academy of Sciences, China.Bioinformatics analysis
To identify klf genes, the nucleotide and amino acid sequences
of the human and mouse Klf family members were used to query
the zebraﬁsh genome (http://www.ncbi.nlm.nih.gov). The full-
length amino acid sequences of 24 Klf proteins from UniProt were
aligned via the CLUSTALW program, and the phylogenetic tree was
generated using the Construct/Test UPGMA Tree program with
MEGA5 software. Chromosomal locations of klf genes were ob-
tained from the zebraﬁsh model organism database (ZFIN),
whereas the protein structures of the Klf family members were
analyzed by integrating the information from the Ensembl zebra-
ﬁsh database (http://asia.ensembl.org/Danio_rerio/Info/Index).
Morpholinos, mRNA and microinjection
The antisense morpholinos (MOs) including klf3-utrMO, klf3-
misMO, frrs1b-atgMO, klf6a-atgMO, p53MO, cdkn1aMO and stan-
dard MO were purchased from GeneTools. The sequences of gene-
speciﬁc MOs are described as follows.
klf3-utrMO (5′-AGCATGGCTGCTTCCAGTGGAATTT-3′),
klf3-misMO (5′-AGGATCGCTCCTTCCACTCGAATT-3′),
frrs1b-atgMO (5′-GAAGCAGCAGTACAATCCACATCAT-3′),
klf6a-atgMO (5′-CACATTGGTAGAACATCCATGCAA-3′) (Veldman
et al., 2007),
p53MO (5′-GCGCCATTGCTTTGCAAGAATTG-3′),
cdkn1a-spliceMO (5′-TAATAAAGAGGTCTGACCTGTGATG-3′)
(Sidi et al., 2008).
Stock solutions at 1 mM in dH2O were prepared, and 4–8 ng
MOs were injected into 1-cell stage embryos at the yolk/blas-
tomere boundary. The pCS2þ plasmid was used to generate the
overexpression constructs of klf3-myc, frrs1b, klf6a-myc and
cdkn1a (primers were provided in Supplemental Table S1). The
mRNAs were synthesized using mMessage mMachine SP6 kit
(Ambion). For overexpression or rescue experiments, 100–200 pg
of mRNAs were injected into 1-cell stage embryos. A partial se-
quence of klf3 gene containing the utr-MO recognition site was
fused with GFP in frame to generate the Klf3–GFP fusion construct
for validation of klf3MO efﬁciency. For rescue experiments, to
avoid the klf6a atgMO recognition, the klf6a full length cDNA was
ampliﬁed with forward primer containing ﬁve silent mutations
and the same reverse primer (Supplemental Table S1), using the
klf6a-myc construct as template. Then the PCR product was cloned
into pCS2þ plasmid for mRNA synthesis. Since the target sequence
of klf3 utrMO is located in the upstream 5′-UTR region of klf3 gene,
there was no need to modify the klf3 full length mRNA for rescue
experiments.
Whole-mount in situ hybridization
Whole-mount in situ hybridization of zebraﬁsh embryos was
performed using a ZF-A4 in situ hybridization machine (Zfand,
China) with probes targeting genes of the klf family, gata1, scl, be1-
globin, pu.1, cdkn1a,mcl1b, bcl2-L10, wee1, ank1, rragd, crip1, acp5a,
acp5b, unc13d, frrs1a, frrs1b, bag1, acot9.1, acot9.2, anxa5a, anxa5b,
capg, ctnnal, glipr2, pqlc3 and alas2 as previously described (Wang
et al., 2011). The primers used in probes synthesis are provided in
Supplemental Table S2.
O-dianisidine staining
To detect the hemoglobin level, zebraﬁsh embryos were
stained with o-dianisidine staining solution for 15–60 min in the
dark as previously reported (Detrich et al., 1995).
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Total RNA used for quantitative RT-PCR (qPCR) was collected
from the trunk region dissected from control and morphant em-
bryos at 24 and 36 hours post fertilization (hpf), and at 2 days post
fertilization (dpf). Total RNA was extracted by TRIzol reagent and
was reversely transcribed. The cDNAs were all diluted 4 times to
be used as templates. The qPCR primers used in this work were
summarized in Supplemental Table S3. The detailed protocols
were described previously (Wang et al., 2011). Three independent
experiments were performed. The qPCR results were analyzed
using SPSS software.
Western blotting
Protein level of Klf3, Frrs1b, Cdkn1a and Klf6a was evaluated
using Western blotting as described previously (Wang et al., 2011),
to verify the efﬁciency of overexpression of klf3 mRNA, klf6a
mRNA, frrs1b mRNA, cdkn1a mRNA and klf6aMO knockdown.
About 50–100 control embryos, frrs1b mRNA or klf6aMO injected
embryos were collected for protein extraction. The following an-
tibodies were used: Klf6 (sc-7158, Santa Cruz Biotechnology),
c-Myc (9e10, Santa Cruz Biotechnology), and Flag (F7425, Sigma).
Cell sorting
Embryos were prepared for FACS as described by Covassin et al.
(2006). The dsRed-positive cells were sorted from ﬂk1:GFP/gata1:
dsRed transgenic embryos using MoFlo XDP (Beckman).
Blood-smear and Giemsa staining
Zebraﬁsh blood cells were collected from the heart region or
vessels using an oil pressure injector and attached to slides by
centrifugation using a cytospin. After the slides were air dried
overnight, Wright–Giemsa staining was carried out to label ery-
throcytes according to the standard protocol. The images were
acquired using a Nikon ECLIPSE 80i (100 ).
TUNEL, BrdU labeling and pH3 staining
TUNEL and BrdU assay were performed as described previously
(Wang et al., 2011). For anti-phosphohistone H3 (pH3) antibody
staining, the Tg (gata1:dsRed) embryos were collected at 2 hpf and
ﬁxed in 4% paraformaldehyde (PFA). The ﬁxed embryos were de-
hydrated with methanol and kept at 20 °C overnight. After re-
hydration, the embryos were treated with Proteinase K (10 mg/ml)
for 20 min at room temperature (RT) and reﬁxed in 4% PFA for
20 min. After washing with PBST, the embryos were blocked in
10% goat serum for 2 hpf at RT and incubated with primary rabbit
anti-phosphohistone H3 antibody (Cell Signaling) at 4 °C over-
night. After washing with PBST, the embryos were incubated with
anti-rabbit-Ig-ﬂuorescein (1:500) at 4 °C overnight.
Promoter constructs and reporter assay
To generate ﬁreﬂy luciferase reporter construct, a 1.5 kb
(4080 bp to 2510 bp) fragment of cdkn1a promoter, and a
2.3 kb (2274 bp to þ91 bp) fragment of frrs1b promoter were
ampliﬁed from zebraﬁsh genomic DNA and inserted into the
pGL3.0 expression vector. To generate Klf3 and Klf6a over-
expression constructs, the full length of klf3 and klf6a coding se-
quences were ampliﬁed from zebraﬁsh cDNA and inserted into
pcDNA3.1(þ) expression vector. Reporter assay was performed as
previously described (Wang et al., 2013).ChIP assay
Chromatin immunoprecipitation (ChIP) assay was carried out
with 24 hpf or 36 hpf embryos injected with klf3-myc or klf6a-myc
mRNA respectively, and the eluted DNA (precipitated by Myc an-
tibody) was assayed by PCR as previously described (Wang et al.,
2013). The primers speciﬁc and nonspeciﬁc to the Klf3 binding site
within the promoter regions of frrs1b or Klf6a binding site within
the promoter regions of cdkn1a were designed according to the
conserved binding sites. The primers were summarized in Sup-
plemental Table S1. Nonspeciﬁc primers and rabbit puriﬁed im-
munoglobulin G were included as controls.
Confocal imaging and Statistical analysis
Confocal images were acquired by a Zeiss LSM 510 META con-
focal laser microscope, and Zeiss LSM software (Carl Zeiss) was
used to generate 3D projections. Student's unpaired 2-tailed t-test
was applied for comparisons unless otherwise indicated.Results
Phylogenetic analysis and expression patterns of Klf family members
in zebraﬁsh
Bioinformatics analysis identiﬁed a total of 24 Klf family
members in zebraﬁsh (based on the latest update of the ZV9 da-
tabase), each of which has a mammalian homolog. The chromo-
somal locations and genomic IDs of the proteins were acquired
from ZFIN and NCBI (Supplemental Table S4). The full-length
amino acid sequences of the zebraﬁsh Klf proteins were obtained
from NCBI and UniProt and used to generate a phylogenetic tree
(Fig. 1A).
Phylogenetic analysis of the Klf family identiﬁed 4 Klf sub-
groups in zebraﬁsh, which is consistent with the classiﬁcation of
their mammalian counterparts (Nagai et al., 2009) (Fig. 1A). Klf
family members share a common conserved C-terminus and have
highly varied N-terminal domains, which were used to group the
Klf proteins (Fig. 1B). Members in both group 1 (Klfd, Klf2a, Klf2b,
Klf4, and Klf17) (Evans et al., 2007; SenBanerjee et al., 2004; Zhang
and Bieker, 1998) and group 2 (Klf5a, Klf5b, Klf6a, Klf6b, Klf7a,
Klf7b, and Klf18) (Li et al., 2005; Matsumoto et al., 1998; Zhang and
Teng, 2003) interact with co-activators such as the histone acet-
yltransferases CBP and p300 and share a basic R/K-rich region
N-terminal to the zinc ﬁnger domains that might function as a
nuclear localization signal (NLS). The group 1 proteins contain a
conserved Asp/Glu-rich region in their N-terminus, whereas group
2 contains more Asp/Leu-rich residues, indicating that the two
groups utilize different cofactors to act as transcriptional activa-
tors. Group 3 members including Klf3, Klf8, Klf12a, and Klf12b can
bind to CtBP, a co-repressor, to recruit HDACs to form a tran-
scriptional repressor complex (Schuierer et al., 2001; Turner and
Crossley, 1998; van Vliet et al., 2000). Members of group 4 (Klf9,
Klf10l, Klf11a, Klf11b, Klf13, and Klf16) (Brubaker et al., 2000;
Fernandez-Zapico et al., 2003; Gowri et al., 2003; Kaczynski et al.,
2001; Kaczynski et al., 2002; Zhang et al., 2001) interact with the
Sin3 A protein through a conserved N-terminal Sin3A-binding
motif, which in turn recruits chromatin remodeling and histone
modiﬁcation enzymes, thus facilitating gene transcriptional acti-
vation or repression. Our results are consistent with a previous
report (Nagai et al., 2009) indicating that the Klf family is highly
conserved between zebraﬁsh and mammals.
To characterize the expression pattern of Klf family genes in
zebraﬁsh, we synthesized RNA probes of 24 klf genes and ex-
amined their expression at two critical hematopoietic stages (24
Fig. 1. Phylogenetic analysis of zebraﬁsh klf genes. (A) The phylogenetic tree was generated using the full-length amino acid sequences of the Klf proteins and the MEGA5
software. The Klf family in zebraﬁsh contains 24 members and was categorized into 4 distinct groups depending on protein structure analysis. (B) Schematic representation
of the Klf family protein structures. The conserved Krüppel-like domain containing three zinc ﬁnger structures is localized in the C-terminus, and divergent functional
domains required for transcriptional activation and repression are located in the N-terminus. The N-terminus of the proteins in Group 1 is enriched in Asp/Glu, whereas
those of the proteins in Group 2 are enriched in Asp/Leu. Group 3 factors share a conserved CtBP binding site, and Group 4 members contain a Sin3A binding site.
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S1A and B). Expression proﬁling indicated overlapping or distinct
expression patterns among the Klf members. For example, klf2b,
klf4 and klf15 were highly expressed in epidermal cells, although
klf15 expression was also detected in myotomes. klf7a was re-
ported to be expressed in the diencephalon of zebraﬁsh (Li et al.,
2010), and here, we detected expression of klf7a in the dorsal
thalamus and the olfactory bulb and the expression of klf7b in the
cranial ganglion. There were also several newly isolated klf factors
that showed a speciﬁc expression pattern in zebraﬁsh. For ex-
ample, klf13 was found to be expressed in the spinal cord, klf6b
and klf12b were present in the metencephalon, and klf12a was
expressed in the olfactory placode.
Several Klf family members have been implicated in hemato-
poiesis in zebraﬁsh. klfd plays an important role in erythropoiesis
by promoting the expression of the embryonic alpha-globin gene
(Fu et al., 2009), and klf17 is essential for erythroid differentiation
by regulating gata1 and beta-globin expression (Gardiner et al.,
2007; Kawahara and Dawid, 2001). Additionally, klf2a is required
for the maintenance of HSC programming (Wang et al., 2011). Our
data showed that klfd, klf2a, and klf17 were expressed in hema-
topoietic cells (Fig. S1A and B), which is consistent with previous
studies (Oates et al., 2001). To gain more insights into the func-
tions of the klf genes in hematopoiesis, we focused on the genes
speciﬁcally expressed in the intermediate cell mass (ICM) and
caudal hematopoietic tissue (CHT) regions (Fig. S1A and B, black
arrowhead). Interestingly, klf3 and klf6a were expressed in the ICM
or CHT region, and their functions have not been previously stu-
died in zebraﬁsh. Therefore, we next focused on the expression,
function and mechanism of action of klf3 and klf6a in zebraﬁsh.
Detailed expression of klf3 and klf6a in zebraﬁsh
During early development in zebraﬁsh, klf3 expression was
detected speciﬁcally in the lateral plate mesoderm (PLM) at the 10somite (s) stage (14 hpf) and in the ICM region at 24 hpf (Fig. S2A).
To further validate the expression of klf3 in hematopoietic and/or
endothelial cells, we tested whether expression of klf3 was af-
fected in hematopoietic mutants such as cloche, etsrp, and moon-
shine. cloche mutants exhibit the earliest hematopoietic and en-
dothelial lineage defects, etsrp mutants have defective blood ves-
sels, and moonshine mutants lack primitive red blood cell (Pham
et al., 2007; Ransom et al., 2004; Stainier et al., 1995). The ex-
pression of klf3 was completely absent in cloche embryos at 26 hpf
(Fig. 2A), suggesting that klf3 is expressed in hematopoietic and/or
endothelial cells. In etsrp mutants, the expression of klf3 did not
change compared with wild type, whereas expression of klf3 was
hardly detected in moonshine mutants. These data indicate that
klf3 is expressed in primitive hematopoietic cells.
The zebraﬁsh klf6a gene is a homolog of mammalian klf6 (Sup-
plemental Table S4). WISH results showed that klf6a was expressed
in the neural plate and the notochord at the 5–10 somite stages.
klf6a was expressed in the central nervous system and blood ves-
sels, including in the head and caudal region, at 24 and 36 hpf (Fig.
S2B). However, klf6a expression was enriched in the gut and swim
bladder at later stages. To verify the hematopoietic and/or vascular
expression of klf6a, we tested the expression of the gene in the
three aforementioned mutants. Interestingly, compared with con-
trol embryos, klf6a expression was markedly decreased in cloche
mutants and etsrp mutants but was only slightly altered in moon-
shine mutants at 30 hpf (Fig. 2B). These data indicate that klf6a
might be associated with vascular and/or hematopoietic develop-
ment. Furthermore, klf3 and klf6a were enriched in gata1 positive
cells isolated from gata1:dsRed transgenic line (Fig. S2C), supporting
their potential roles in primitive erythroid cells.
Knockdown of klf3 affects the maturation, but not the initiation, of
primitive erythrocytes
To explore whether klf3 is required for primitive hematopoiesis,
Fig. 2. The expression of klf3 andklf6a in cloche, etsrp, and moonshine mutants. (A) The expression of klf3 was lost in cloche and moonshine mutants, whereas no change was
observed in etsrpmutants at 26 hpf. The arrowheads mark red blood cells in the ICM. (B) klf6a expression in cloche and etsrpmutants was greatly decreased, but only slightly
reduced in moonshine mutants at 30 hpf. The arrowheads mark klf6a expression in the posterior ICM region. Anterior is shown to the left, with dorsal to the top.
Fig. 3. Maturation of erythrocytes was blocked inklf3 morphants. (A) The expressions of gata1 and be1-globin did not change in klf3 morphants at 24 hpf. However, the
expressions of be1-globin and be3-globin were remarkably decreased during the differentiation and maturation of blood red cells at 36 hpf. The arrowheads mark RBCs in
CHT. (B) O-dianisidine staining of hemoglobin during erythropoiesis. At 36 hpf and 2 dpf, the staining in klf3 morphants was signiﬁcantly reduced, indicating that the
maturation of RBCs was blocked. The RBCs in the heart region are indicated by arrowheads. (C) Blood-smear and Giemsa staining. At 2.5 dpf, the size and nucleo-cytoplasmic
ratio of RBCs from klf3 morphants were increased compared with those of controls, indicating the arrest of erythroid cell maturation. The arrowhead marks the delayed
erythroid progenitor. (D) Quantiﬁcation of the nucleo-cytoplasmic ratio between controls and klf3morphants (mean7SD, ***P o0.001, n¼15). The nucleo-cytoplasmic ratio
was calculated as follows: the diameter of nucleus (D1) and whole cell (D2) were measured by Photoshop, and the nucleo-cytoplasmic ratio (NCR) was calculated using
formula
⎛
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. Each sample contains 15 cells in controls and morphants.
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klf3 expression in zebraﬁsh. To verify the MO efﬁciency, a Klf3–GFP
fusion construct was generated in which a partial sequence of the
klf3 gene containing the utr-MO recognition site was fused with
GFP in frame, and this construct was co-injected with klf3MO or
klf3-utr-misMO (misMO). The results showed that GFP expression
was markedly abolished by klf3MO injection but not by klf3-mis-
MO, indicating the high efﬁciency of this utr-MO (Fig. S3A). We
next examined the expression of primitive hematopoietic markers
in klf3 morphants by WISH. At 24 hpf, the expression of erythroid
markers gata1 and be1-globin was normal (Fig. 3A), and the ex-
pression of the vascular endothelial marker ﬂk1, the early myeloid
marker pu.1 and the early hematopoietic marker scl did not change
compared with the control embryos (Fig. S3B). The erythromyeloid
progenitor markers lmo2, gata1 and l-plastin seemed normal at
30 hpf in klf3 morphants (Fig. S3C). These data demonstrated that
klf3 was not involved in the initiation of primitive hematopoiesis.
However, at later stages, the expression of be1-globin and be3-
globin was decreased at 36 hpf (Fig. 3A). The expression of mature
erythroid cells markers, such as ae1-globin, transferrin (tf) and
transferrin receptor (tfR), was downregulated at 2 dpf (Fig. S3D) in
klf3 morphants, indicating that the differentiation of erythroid
cells was affected. To verify this effect, we performed o-dianisidine
staining to label mature red blood cells (RBCs). O-dianisidine
staining revealed that the number of RBCs in klf3 morphants was
dramatically reduced at 36 hpf and 2 dpf (Fig. 3B), whereas no
obvious changes were observed when the same dose of klf3-mis-
MO was injected (Fig. S3A lower panels), indicating that the dif-
ferentiation of primitive erythrocytes was affected by knockdown
of klf3. To further demonstrate that the phenotype was speciﬁc to
klf3 knockdown, we injected klf3 mRNA (with sequence that does
not overlap with MO) into klf3 morphants. The result showed that
the expression of be1-globin was rescued (Fig. S3E and F). To fur-
ther support the observed erythroid maturation defect, RBCs were
collected from 2.5 dpf embryos and subjected to Wright–Giemsa
staining, which deﬁnes the different developmental stages of the
erythroid lineage, ranging from erythroblasts to erythrocytes, in
zebraﬁsh (Qian et al., 2007). Compared with the control, the nu-
cleo-cytoplasmic ratio of RBCs was increased in klf3 morphants
(Fig. 3C and D), suggesting that the maturation of RBCs was
blocked at the early stages of erythropoiesis. To exclude the pos-
sibility that the reduced RBCs were due to apoptosis, we per-
formed TUNEL assay. As expected, there was no obvious difference
in klf3 morphants compared to controls (Fig. S3G). Taking these
results together, we conclude that klf3 plays a critical role in ery-
throid maturation during primitive hematopoiesis.
Frrs1b is directly regulated by klf3 during erythropoiesis in vivo
To gain insight into the mechanism by which klf3 regulates the
maturation of erythrocytes, we took advantage of a bioinformatics
approach to analyze databases of published literature (Funnell
et al., 2012; Tallack et al., 2010; Turchinovich et al., 2011). Because
Klf3 acts as a transcriptional repressor, we would expect upregu-
lated expression of its direct target genes when Klf3 was depleted.Fig. 4. Frrs1b is downstream ofklf3 in the regulation of erythropoiesis. (A) Upper panels
the expression of frrs1b was decreased in klf3 mRNA-injected embryos. The arrowheads i
attenuated in frrs1b overexpressed embryos at 36 hpf, similar to the phenotype of klf3 kno
showed that frrs1b or be1-globin expressions were decreased when overexpression of klf
staining was partially rescued when klf3 morphants were injected with frrs1bMO at 2 d
frrs1b promoter that was used in the reporter and ChIP assays. (F) ChIP-PCR. frrs1b-NF/NR
without the conserved Klf binding site. The frrs1b-F/R primers were used to amplify the
zebraﬁsh Klf3 in HEK293T cells. Actin was used as a loading control. Klf3 protein express
samples was normalized to the control, and the relative luciferase activity was calculated
cells were co-transfected with the Renilla reporter plasmid, the frrs1b promoter constru
changed to ACAA, and pCDNA-FLAG-Klf3. Luciferase assays were performed using the DAfter screening, our analysis generated a list of 17 genes that were
highly expressed in the developing erythrocytes of klf3 / mutant
mice (Funnell et al., 2012). We subsequently evaluated the ex-
pression of these 17 genes (20 genes in the zebraﬁsh genome due
to gene duplication) in zebraﬁsh klf3 morphants at 24 and 36 hpf
by WISH, and found that the expression of 5 genes (frrs1b, glipr2,
klf8, capg, and bag1) was signiﬁcantly increased in klf3 morphants
compared with controls (Fig. 4A upper panels; data not shown).
qPCR analysis was also consistent with the WISH results (Fig. S4A).
Among these genes, the expression pattern of frrs1b was similar to
that of klf3, as double ﬂuorescence in situ hybridization demon-
strated that frrs1b co-localized with klf3 in the ICM region at
24 hpf (Fig. S4B). In addition, the expression of frrs1b was reduced
when klf3 mRNA was injected (Fig. 4A middle panels), and qPCR
analysis was also consistent with the WISH result (Fig. 4B). Hence,
we propose that frrs1b might be a direct downstream target of
Klf3. To determine whether upregulation of frrs1b expression is
responsible for the klf3 knockdown phenotype, frrs1b mRNA was
synthesized and injected into 1-cell stage wildtype embryos.
Strikingly, as shown in Fig. 4A lower panels, the expression of be1-
globin was remarkably attenuated, which was consistent with the
phenotype in klf3 morphants, and qPCR analysis conﬁrmed the
WISH result (Fig. 4B). To determine whether the upregulation of
frrs1b was responsible for the RBC maturation defects observed in
klf3 morphants, we employed a double-knockdown approach.
Importantly, double knockdown achieved by co-injecting klf3MO
and frrs1bMO partially rescued the expression of be1-globin at
36 hpf and 2 dpf (Fig. S4C and D). Moreover, the intensity of
o-dianisidine staining was rescued by double knockdown of klf3
and frrs1b at 2 dpf (Fig. 4C), suggesting that frrs1b is required for
klf3-regulated RBC maturation. To test whether Klf3 directly reg-
ulates frrs1b expression by binding to its promoter, ChIP analysis
was performed. We analyzed the frrs1b upstream regulatory re-
gion and found a conserved Klf binding motif (CACCC) in this re-
gion (Fig. 4D and E). ChIP-PCR showed that frrs1b was speciﬁcally
enriched in the Klf3-myc Ab pulldown compared with that of IgG
(Fig. 4F). We then cloned the frrs1b upstream regulatory region
containing the conserved Klf binding motif (CACCC) and per-
formed a reporter assay. Western blots showed that Klf3 was ex-
pressed in vitro after the transfection of pCDNA-FLAG-Klf3 into
HEK293T cells (Fig. 4G). Subsequent reporter assay showed that
luciferase activity was strongly repressed in a dose-dependent
manner when pCDNA-FLAG-Klf3 was co-transfected with the
pGL3-frrs1b promoter but not when it was co-expressed with a
mutant promoter (Fig. 4H and I). Together, we conclude that frrs1b
is a direct downstream target that is repressed by Klf3 during er-
ythropoiesis in vivo.
Differentiation and maturation of erythroid progenitors are blocked
in klf6a morphants
Previous studies reported that klf6 / mice exhibited embryonic
anemia and early lethality (Matsumoto et al., 2006). To determine
the function of klf6a during blood cell generation and vasculogenesis
in zebraﬁsh, we used klf6a-atg MO to speciﬁcally knock down klf6a,, the expression of frrs1b was increased in klf3 morphants at 24 hpf; middle panels,
ndicate the expression of frrs1b in the ICM; lower panels, be1-globin expression was
ckdown embryos. The arrowheads mark the expression in the ICM. (B) qPCR results
3 or frrs1b, respectively (mean7SD, t-test, ***Po0.001, n¼3). (C) The o-dianisidine
pf. (D) The conserved core binding site of Klfs. (E) The schematic structure of the
are negative control primers that were used to amplify the frrs1b promoter region
promoter region containing the conserved Klf3 binding site. (G) Overexpression of
ion was detected with anti-FLAG antibody. (H and I) The luciferase activity of tested
from three independent experiments (mean7SD, t-test, *Po0.05, n¼3). HEK293T
ct or a mutant frrs1b promoter construct in which the Klf3 binding site CACC was
ual-Luciferase Reporter Assay System.
Fig. 5. klf6a knockdown induces a blockage of erythroid cell differentiation and maturation. (A) WISH results showed that gata1 expression was comparable between
controls and klf6a morphants from 24 hpf. The expression of be1-globin and be3-globin was decreased in klf6a morphants, compared with controls at 36 hpf and 2 dpf.
(B) The number of o-dianisidine-positive cells (marked by arrowheads) decreased dramatically in klf6a morphants between 40 hpf and 2 dpf. (C) The real time PCR results
displayed that ae1-globin and be1-globin were downregulated in klf6a morphants at 36 hpf and 2 dpf (mean7SD, *P o0.05, **P o0.01, n¼3). (D) Giemsa staining of
erythroid cells from the blood of controls and klf6a morphants at 2.5 dpf. The size and nucleo-cytoplasmic ratio of red blood cells in klf6a morphants were noticeably larger
than those of controls. The arrowhead marks the delayed erythroid progenitor. (E) Quantiﬁcation of the nucleo-cytoplasmic ratio between controls and klf6a morphants
(mean7SD, nnP o0.01, n¼19).
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indicated that there were no detectable differences in the expression
of ﬂk1 and early hematopoietic markers (scl, pu.1 and gata1) at
24 hpf between control embryos and klf6amorphants (Fig. 5A upper
panels; Fig. S3B). The erythromyeloid progenitor (EMP) markers
were not changed at 30 hpf in klf6a morphants (Fig. S3C). We also
performed microscopy to observe blood circulation and found that it
was normal in klf6amorphants (Movie S1). However, be1-globin and
be3-globin expressions were decreased in klf6a morphants at 36 hpf
and 2 dpf (Fig. 5A middle and lower panels). Moreover, o-dianisidine
staining analysis showed that the morphants possessed fewer ma-
ture erythrocytes at 40 hpf and 2 dpf (Fig. 5 B). The qPCR results
displayed that ae1-globin and be1-globin were down-regulated at
36 hpf and 2 dpf (Fig. 5 C). As shown in Fig. S5B, the expressions of tf
and tfr were also reduced at 36 hpf in klf6a morphants. These
ﬁndings indicated that the differentiation and maturation, but not
the speciﬁcation, of the erythroid lineage were blocked in klf6a
morphants. We also performed blood-smear Giemsa staining to
determine the developmental stages of the erythroid cells.Compared with control embryos, there were more naïve erythroid
progenitors with larger nuclei (erythroblasts) in klf6a morphants
(Fig. 5 D and E). To determine the phenotype induced by klf6aMO
was speciﬁc, we co-injected klf6a morpholino and klf6a mRNA
modiﬁed to avoid binding by klf6aMO. qPCR and o-dianisidine
staining results showed that be1-globin expression was rescued by
co-injection (Fig. S5C and D). TUNEL assay also showed that there
was no obvious difference in klf6a morphants compared to control
embryos (Fig. S3G). Together, these data demonstrate that primitive
erythroid differentiation and maturation are arrested in klf6a
morphants.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2015.05.015.
Increased expression of cdkn1a, a downstream target of klf6a, is re-
sponsible for cell cycle arrest in klf6a morphants
To determine the downstream targets of klf6a during this reg-
ulation, we examined the expression of genes related to
Fig. 6. Cdkn1a acts downstream of klf6a to negatively regulate erythroid cell maturation by inducing cell cycle arrest. (A) Scheme of cell sorting by FACS. The
gata1:dsRed-positive cells were sorted from the transgenic line ﬂk1:GFP/gata1:dsRed at 2 dpf. (B) qPCR showed cdkn1a upregulation in the sorted cell population of klf6a
morphants (mean7SD, t-test, *Po0.05, n¼3). (C) qPCR analysis showed that cdkn1a was decreased in klf6amRNA-injected embryos at 36 hpf (mean7SD, t-test, **Po0.01,
*Po0.05, n¼3). (D) O-dianisidine staining showed that the number of mature RBCs was reduced in klf6a morphants and cdkn1a mRNA-injected embryos, and the defect in
klf6a morphants was rescued by co-injection of cdkn1aMO. The arrowheads mark o-dianisidine-positive cells. (E) Analysis of Klf6a binding to the cdkn1a promoter by ChIP
assay. The schematic of the cdkn1a promoter structure that was used in the reporter and ChIP assays. (F) ChIP-PCR. cdkn1a-NF/NR were negative control primers that were
used to amplify the cdkn1a promoter region without the conserved Klf6a binding site. The cdkn1a-1F/1R primers were used to amplify the promoter region containing the
conserved Klf6a binding site. (G) Reporter assay. Western blot analysis of overexpression of zebraﬁsh Klf6a in HEK293T cells. (H) HEK293T cells were co-transfected with the
promoter construct of cdkn1a containing the conserved Klf6 binding sites (GGGCGG) or mutated sites (TTTAAA) and the pCDNA-Klf6a plasmid. (I) BrdU and pH3 staining
indicated the gata1:dsRed positive cells in S and M phases in CHT region of 2 dpf Tg (gata1:dsRed) embryos. The yellow arrowheads mark the erythrocytes in S/M phase.
(J) The statistic graph showed the percentages of BrdUþgata1:dsRedþ and pH3þgata1:dsRedþ in the CHT region (mean7SD, t-test, *Po0.05, n¼5).
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mice by bioinformatics. There was no obvious difference in the
expression of bcl2-L10, mcl1b, and NF-kBiA-b between control and
klf6a morphants (Fig. S5E). Among the predicted target genes, we
only detected a dramatic upregulation of cdkn1a expression in
klf6a morphants, especially at 25 and 36 hpf. To understand the
mechanism underlying the erythroid maturation defects in klf6a
morphants, we sorted gata1:dsRed positive cells from ﬂk1:GFP/
gata1:dsRed transgenic embryos by ﬂow cytometry (Fig. 6A). Our
real-time PCR analysis showed that cdkn1a expression was upre-
gulated in sorted gata1:dsRed positive erythroid lineage cells in
klf6a morphants (Fig. 6B) but decreased in embryos over-
expressing klf6a (Fig. 6C). These results indicated that cdkn1a was
a downstream target gene of klf6a in zebraﬁsh. Furthermore,
overexpression of cdkn1a mimicked the phenotype of klf6a mor-
phants, and co-injecting cdkn1aMO with klf6aMO rescued the re-
duced o-dianisidine staining (Fig. 6D), and be1-globin expression
level which was detected by WISH (Fig. S6A) and qPCR (Fig. S6B).
To determine whether Klf6a directly regulates cdkn1a, we ana-
lyzed the cdkn1a upstream regulatory region and found a con-
served Klf6a binding motif (GC-box) in this region (Fig. 6E). ChIP
assays using 36 hpf zebraﬁsh embryos demonstrated that Klf6a
bound to the promoter of cdkn1a in vivo (Fig. 6F). For reporter
assay, we generated a promoter construct of cdkn1a that contained
the conserved Klf6a binding sites or mutated binding sites
(Fig. 6E). Klf6a protein overexpression in vitro was observed by
Western blot only in HEK293T cells that were transfected with
pCDNA-Klf6a (Fig. 6G). We found that Klf6a repressed cdkn1a
promoter activity in a dose-dependent manner but did not affect
promoter activity when the Klf6a binding sites were mutated
(Fig. 6H). cdkn1a (also called p21) encodes a cyclin-dependent
kinase inhibitor that plays an important role in regulating the cell
cycle. Increased expression of cdkn1a induced cell cycle arrest at S
and G2/M phases (Wu et al., 2013). To further determine the cell
cycle status, we performed a BrdU assay to monitor the cycling
cells in S phase in the Tg (gata1:dsRed) line. In morphant embryos,
there were more gata1:dsRed-positive cells labeled with BrdU
(Fig. 6I) and the percentage of BrdUþgata1:dsRedþ cells in klf6a
morphants increased to 27.8% compared with 20.4% in control
embryos (Fig. 6J). We then performed anti-phospho-histone H3
(pH3) antibody staining to estimate the mitotic number of cells
and the percentage of gata1:dsRed cells labeled by pH3 staining
was approximately 6% in control embryos, but the ratio in the klf6a
morphants was decreased to 4% (Fig. 6I and J). The opposite pat-
tern occurred in S and M phases in klf6a morphants, indicating
that there was S phase arrest but not active cell proliferation. Ta-
ken together, these results indicate that Klf6a directly represses
cdkn1a expression to regulate the normal cell cycle during ery-
throid progenitor maturation.
cdkn1a is also tightly regulated by p53 signaling, and non-
speciﬁc MO toxicity often causes p53-dependent cell death in MO-
injected embryos (Robu et al., 2007). To further demonstrate that
the increased expression of cdkn1a in klf6amorphants was speciﬁc
to klf6a knockdown and not attributed to nonspeciﬁc MO injection
effects, we injected klf6aMO into p53 mutant zebraﬁsh embryos.
The decrease in the number of red blood cells was still observed in
the injected p53 mutant, albeit to a lesser extent (Fig. S6C). p53 is
known to be an upstream regulator of cdkn1a; therefore, it is not
surprising that p53 mutation or knock down can alleviate the
phenotype caused by increased cdkn1a expression in klf6a mor-
phants. qPCR results showed that be1-globin expression was re-
duced and cdkn1a was still upregulated in klf6aMO and p53MO co-
injected embryos, compared to klf6a single knockdown embryos
(Fig. S6D), suggesting that cdkn1amight be separately regulated by
klf6a and p53. Our results and previous studies have indicated that
as a transcription factor, klf6 directly binds to cdkn1 (Narla et al.,2001) and that loss of klf6 also directly results in p53 up-regulation
(Sirach et al., 2007). It is possible that negative regulation of
cdkn1a by Klf6a involves two pathways: a p53-dependent and a
p53-independent pathway.
Double knockdown of klf3 and klf6a causes more severe erythroid
maturation defects in zebraﬁsh
To explore the potential functional interaction between klf3 and
klf6a, we performed a double knockdown of klf3 and klf6a (Fig. S7).
In double-knockdown morphants, the number of mature RBCs was
more severely attenuated compared with single knockdown of
either klf3 or klf6a (Fig. S7A). Simultaneously, the expression of
be1-globin was also remarkably reduced (Fig. S7B), whereas the
population of gata1 positive erythroid progenitors increased ac-
cordingly (Fig. S7C). Considering the redundancy of the Klf family,
the expression of Klf family members involved in hematopoiesis
was determined by WISH. Interestingly, the expression of klf3 in
the ICM was not affected in klf6a morphants and vice versa (Fig.
S8), indicating that their expressions were not reciprocally con-
trolled and that there was no compensatory effect for loss of either
gene. Similarly, the other klf genes, including klfd, klf2a and klf17,
were not affected by knockdown of klf3 or klf6a in zebraﬁsh (Fig.
S8). Taken together, these data suggest a cooperative effect of
these two members of the Klf family (klf3 and klf6a) in regulating
erythropoiesis.Discussion
Several Klf family members have been shown to be involved in
hematopoiesis in mammals. Nonetheless, our understanding of
the roles of the entire Klf family in hematopoiesis is far from
complete. To comprehensively explore the Klf family, we per-
formed bioinformatics analysis using zebraﬁsh as a model and
identiﬁed a total of 24 klf genes in the zebraﬁsh genome. Gene
expression proﬁling showed that 6 genes (klfd, klf2a, klf3, klf6a,
klf8, and klf17) were expressed in hematopoietic and/or en-
dothelial cells during embryogenesis. Among these genes, the
roles of klf3 and klf6a in zebraﬁsh hematopoiesis have not been
reported to our knowledge. Through functional and mechanistic
studies, we demonstrated that both klf3 and klf6a are important
for erythroid cell maturation but that they act in distinct manners.
Our ﬁndings provide novel insights into the molecular mechan-
isms of klf gene action during vertebrate embryogenesis, particu-
larly during erythropoiesis.
In mammals, there are at least 17 klf genes (Nagai et al., 2009),
whereas our bioinformatics analysis identiﬁed a total of 24 klf
genes in zebraﬁsh. Our phylogenetic tree analysis showed that the
zebraﬁsh genome contains 7 pairs of duplicated klf genes, in-
cluding klf2a and klf2b, klf5a and klf5b, klf6a and klf6b, klf7a and
klf7b, klf11a and klf11b, klf12a and klf12b, and klf15 and klf15-like.
The extra copies of the zebraﬁsh klf genes appear to arise from a
whole-genome duplication during evolution of the teleost (Post-
lethwait et al., 1998). Interestingly, the duplicated zebraﬁsh klf
genes often have distinct expression patterns. For example, klf2a is
expressed in blood and endothelial cells, whereas klf2b is ubiqui-
tously expressed at a very low level. Similarly, klf6a is speciﬁcally
expressed in dorsal ganglia and caudal vascular tissue, whereas
klf6b is expressed in the whole embryo. These observations in-
dicate that after genome-wide duplication during evolution, the
zebraﬁsh-speciﬁc klf genes may have acquired distinct expression
patterns and functions to fulﬁll the complex requirements of the
organism.
klf3, which is known as bklf in mammals, is a master regulator
during erythropoiesis. Previous studies in mice had shown that
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during erythrocyte maturation (Eaton et al., 2008; Funnell et al.,
2007, 2012). Expression of several downstream target genes in-
cluding klf8, lgals3, and fam132a was signiﬁcantly increased in klf3
KO mice. Nonetheless, the molecular pathways downstream of
Klf3 remained largely unclear. In our study, we identiﬁed a novel
gene, frrs1b, which is a downstream target gene of Klf3. Ferric-
chelate reductase 1 (Frrs1), which is also known as stromal cell-
derived receptor 2 (SDR2), is a member of the cytochrome b561
family. Members of this family reduce ferric iron to ferrous iron
before transport from the endosome to the cytoplasm (Vargas
et al., 2003). frrs1 is highly expressed in the mouse liver, whereas
in the hpx mouse (which exhibits an increased absorption of iron),
the mRNA level of frrs1 was dramatically reduced. As a member of
cytochrome family, frrs1bmight be involved in mitochondrion iron
metabolism. Mitochondrion is an important site of heme synthesis
and plays a critical role in iron metabolism (Richardson et al.,
2010). Mitochondrion ferritin (Ftmt), which is located on the mi-
tochondrion membrane, regulates the iron balance between cy-
toplasm and mitochondrion. When Ftmt was overexpressed, the
level of cytosolic iron was reduced, leading to iron-overload in the
mitochondrion (Nie et al., 2005). The similar phenomenon was
also shown in Friedreich's ataxia patients, in which (frataxin-de-
ﬁciency) the heme synthesis was decreased due to iron overload in
the mitochondrion (Li et al., 2008). In our study, the reduced ex-
pression of be1-globin in klf3 morphants was possibly due to
aberrant expression of frrs1b, which in turn led to abnormal iron
metabolism between cytosol and mitochondrion. This was con-
sistent with that the cellular iron homeostasis is important during
erythropoiesis (Ponka, 1997). Future work is still needed to illus-
trate the detailed mechanisms by which frrs1 regulates embryonic
hemoglobin maturation of erythroid cells in vertebrates
Although klf6 was shown to be a regulator of early
hematopoietic development in mice (Matsumoto et al., 2006),
whether or how klf6a affects hematopoietic lineages in other
vertebrates has not been completely determined. Our study de-
monstrates that klf6a is required for erythropoiesis and that klf6a
knockdown leads to erythroid cell maturation defects by up-reg-
ulating cdkn1a, which induces cell cycle arrest. Several studies in
mice showed that cell cycle arrest by p21 up-regulation is required
for terminal erythropoiesis, i.e. from erythroblasts to reticulocytes,
then to mature red blood cells (Siatecka et al., 2010; Tallack et al.,
2009, 2007). However, during zebraﬁsh erythropoiesis there is no
process of enucleation and the mature erythrocytes are still nu-
cleated, so it is possible that the cell cycle arrest might not be
necessary for terminal erythroid maturation in zebraﬁsh. Indeed,
cell cycle progression is essential for the differentiation of early
erythroid precursor/erythroblast in mice (Marinkovic et al., 2007;
Pilon et al., 2008), which is consistent with our observation here in
that klf6a-mediated p21 downregulation is required for erythroid
maturation in zebraﬁsh. Then the decreased number of functional
erythrocytes and increased number of erythroid progenitors
caused by the blockage of erythroid cell differentiation were
strongly associated with a risk of erythroleukemia or anemia.
Therefore, klf6a might act as a candidate target gene in the pa-
thogenesis or for the targeted therapy of erythroleukemia or an-
emia. It had been reported that Klf6 activates cdkn1a to repress
tumors in adult tissues such as the prostate in human (Narla et al.,
2001). However, in our study, klf6a directly repressed cdkn1a,
which appears to be inconsistent with previous results (Narla
et al., 2001). We hypothesized that the same gene/regulator might
play different roles in different contexts. Various tumor suppressor
genes have similar divergent properties between embryonic de-
velopment and adulthood (Matsumoto et al., 2006). Consistently,
knockdown of klf6a decreased hepatocyte proliferation by upre-
gulating cdkn1a in zebraﬁsh (Zhao et al., 2010). Furthermore, it hasbeen demonstrated that klf6 represses cdkn1a by a transcriptional
co-repressor complex (Calderon et al., 2012). Because klf6 is
known to be a transcriptional activator or repressor, it might play
distinct roles depending on the developmental and tissue-speciﬁc
contexts. Our studies demonstrate the function of klf6a in
primitive erythropoiesis in zebraﬁsh and the potential mechanism
by which klf6a negatively regulates cdkn1a expression in
erythrocytes.
The similarity between klf gene-deﬁciency phenotypes in zeb-
raﬁsh and erythroleukemia or anemia, i.e., the blocked maturation
of erythroid progenitors, and the downstream target genes (frrs1b
and cdkn1a) of klf3 and klf6a identiﬁed here might provide new
strategies for leukemia diagnosis and treatment in the clinic.Author contributions
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